Investors announced for 2013 Rocky Mountain Life Science Investor and Partnering Conference

By: InnovatioNews Wednesday September 11, 2013 Tags: Denver, Kyle Lefkoff, Patrick J. Mahaffey, Ron Squarer

DENVER - More than 35 leading investors and strategic partners from across the U.S. will be attending the Rocky Mountain Life Science Investor and Partnering Conference in Denver on Sept. 19.

The annual conference this year will showcase 30 of the region's emerging life science companies presenting their technologies to a targeted audience of potential investors and partners.

The conference is spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah.

The CBSA said the following investors and strategic partners have said they will attend the event:

• Amgen Ventures, Thousand Oaks, CA


• Aphelion Capital, Mill Valley, CA


• BioGenerator, St. Louis, MO


• Boulder Ventures, Boulder


• Charter Life Sciences, Santa Clara, CA


• Covidien, Mansfield, MA


• Epic Ventures, Albuquerque, NM


• GE Healthcare Financial Services, Chicago, IL


• Goodworks Ventures, MT


• High Country Venture, Boulder


• Johnson & Johnson Development Corp., New Brunswick, NJ


• KMG Capital Partners, Denver


• Level 5 partners, Fort Collins


• Lightstone Ventures, Boulder


• Mercury Fund, Houston, TX


• Mile High Fund, Denver


• Morgenthaler Ventures, Menlo Park, CA


• New Enterprise Associates, Menlo Park, CA


• Novartis Venture Funds, Cambridge, MA


• Red Script Ventures, New Brunswick, NJ


• Remeditex, Dallas, TX


• Salt lake Life Science Angels, Salt Lake City, UT


• Sanderling Ventures, San Mateo, CA


• Signal Peak Ventures, Salt Lake City, UT


• Split Rock Partners, Menlo Park, CA


• SR One, Corporate Arm of GlaxoSmithKline, SF, CA


• Technology Partners, Palo Alto, CA


• Telegraph Hill Partners, SF, CA


• Volcano Capital, NYC, NY


• Wayne Brown Institute, SLC, UT


• Wexford Capital LP, Greenwich, CT

An opening reception will be held Sept. 18 in the Governor's Mansion, followed by a full day conference at the Ritz-Carlton on Sept. 19.

Kyle Lefkoff, founder and general partner of Boulder Ventures, will lead a keynote breakfast conversation with the CEOs of two premier publicly traded pharmaceutical companies - Patrick Mahaffey, founder and CEO of Clovis Oncology, and Ron Squarer, CEO of Array BioPharma.

For more information, visit www.RockyMtnBioInvest.com.